comprehensive -WSS

comprehensive

author：leisure time 2025-09-03 03:46:33 - browse：92468

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： The Readout: Lenmeldy, GLP

WSS

Emergency medicine has repudiated 'excited delirium.' Now what?

FDA has safety concerns on CRISPR

Chimpanzees, like humans and whales, get menopause: Study

Primary care physicians play key roles in Alzheimer's management

CDC recommends rationing of RSV shot due to shortages

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

leisure time

comprehensive

explore

BioMarin wins approval for gene therapy to treat hemophilia A

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Duchenne breakthrough therapy leaves behind pioneering families

There's no autism epidemic. It's an autism diagnosis epidemic

How to save PrEP access — and even expand it

Roche subsidiary Foundation Medicine opens new headquarters

New air purifier tech could be key to improving indoor air quality

Eliminate the waiting period for sterilization covered by Medicaid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The pink breast cancer awareness ribbon needs a redesign

explore

FDA has safety concerns on CRISPR

Covid vaccine financial winners and losers, from Pfizer to Novavax

Merck drug for rare lung condition set for approval in U.S.

Roche subsidiary Foundation Medicine opens new headquarters

The Readout: Lenmeldy, GLP

WHO may add ‘noma' to its list of neglected tropical diseases

explore

hotspot

leisure time

Wikipedia